1. Home
  2. SLBT vs DV Comparison

SLBT vs DV Comparison

Compare SLBT & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$2.69

Market Cap

1.5B

Sector

N/A

ML Signal

N/A

Logo DoubleVerify Holdings Inc.

DV

DoubleVerify Holdings Inc.

HOLD

Current Price

$13.31

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLBT
DV
Founded
N/A
2008
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
SLBT
DV
Price
$2.69
$13.31
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
$16.37
AVG Volume (30 Days)
72.2K
4.5M
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.12
Revenue
N/A
$748,291,000.00
Revenue This Year
N/A
$12.68
Revenue Next Year
N/A
$9.75
P/E Ratio
N/A
$110.92
Revenue Growth
N/A
13.92
52 Week Low
$2.54
$7.61
52 Week High
$6.25
$16.44

Technical Indicators

Market Signals
Indicator
SLBT
DV
Relative Strength Index (RSI) 40.10 69.11
Support Level $2.54 $10.07
Resistance Level $3.40 $13.36
Average True Range (ATR) 0.17 0.14
MACD 0.05 0.04
Stochastic Oscillator 0.00 97.36

Price Performance

Historical Comparison
SLBT
DV

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a media effectiveness platform that leverages artificial intelligence (AI) to drive superior outcomes for international brands by creating transparent ad transactions. Its solutions provide unbiased data analytics to improve the effectiveness, quality and return on advertising investments. DV Authentic Ad is its proprietary metric measuring whether an ad was delivered in a brand suitable environment, fully viewable, by a real person and in geography, while DV Pinnacle delivers these metrics in real time. The Company's solutions are integrated across programmatic platforms, social media channels and digital publishers, and are accredited by the Media Rating Council for digital ad measurement. It operates in the United States and international markets.

Share on Social Networks: